Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial
- PMID: 14517527
- DOI: 10.1067/s0022-3476(03)00388-3
Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial
Abstract
We performed a prospective, randomized, open-label equivalence study comparing the use of naproxen to aspirin in 33 patients with rheumatic fever. The mean time until resolution of arthritis was 2.9+/-2.9 days in both groups. Liver enzyme elevations were more frequent in the aspirin group (P=.002). We conclude that naproxen is as effective, is easier to use, and is safer than aspirin in the treatment of the arthritis of rheumatic fever.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
